Insulet Corp Files 8-K: Director, Officer, and Compensation Updates

Ticker: PODD · Form: 8-K · Filed: 2025-09-16T00:00:00.000Z

Sentiment: neutral

Topics: corporate-governance, executive-compensation, filing-update

Related Tickers: PODD

TL;DR

Insulet (PODD) filed an 8-K on 9/11/25 covering director/officer changes and compensation. Watch for strategic implications.

AI Summary

On September 11, 2025, Insulet Corporation filed an 8-K report detailing changes in its board of directors and executive officers, along with updates to compensatory arrangements. The filing also includes information on other events and financial statements/exhibits.

Why It Matters

Changes in a company's board and executive team, especially when tied to compensation, can signal shifts in strategy or governance that may impact future performance.

Risk Assessment

Risk Level: low — This filing primarily concerns corporate governance and executive compensation, which typically carries a lower immediate risk compared to financial distress or major operational changes.

Key Players & Entities

FAQ

What specific changes were made regarding directors or officers?

The filing indicates updates related to the 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers' and 'Compensatory Arrangements of Certain Officers'.

What is the exact date of the earliest event reported in this 8-K?

The date of the earliest event reported is September 11, 2025.

What is Insulet Corporation's state of incorporation?

Insulet Corporation is incorporated in Delaware.

What is the company's principal executive office address?

The principal executive offices are located at 100 Nagog Park, Acton, Massachusetts 01720.

Besides director and officer changes, what other items are covered in this filing?

The filing also covers 'Other Events' and 'Financial Statements and Exhibits'.

From the Filing

0001193125-25-204276.txt : 20250916 0001193125-25-204276.hdr.sgml : 20250916 20250916070556 ACCESSION NUMBER: 0001193125-25-204276 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20250911 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250916 DATE AS OF CHANGE: 20250916 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INSULET CORP CENTRAL INDEX KEY: 0001145197 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 043523891 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-33462 FILM NUMBER: 251315828 BUSINESS ADDRESS: STREET 1: 100 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 BUSINESS PHONE: 978-600-7000 MAIL ADDRESS: STREET 1: 100 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 8-K 1 d67909d8k.htm 8-K 8-K INSULET CORP false 0001145197 0001145197 2025-09-11 2025-09-11     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K     CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 11, 2025     INSULET CORPORATION (Exact Name of Registrant as Specified in Charter)       Delaware   001-33462   04-3523891 (State or Other Jurisdiction of Incorporation)   (Commission File Number)   (IRS Employer Identification No.) 100 Nagog Park , Acton , Massachusetts 01720 (Address of Principal Executive Offices, including Zip Code) Registrant’s telephone number, including area code: (978) 600-7000 Not Applicable (Former Name or Former Address, if Changed Since Last Report)     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock, $0.001 Par Value Per Share   PODD   The NASDAQ Stock Market, LLC       Item 5.02 – Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements with Certain Officers. On September 16, 2025, Insulet Corporation (the “Company”) announced that Flavia H. Pease has been appointed to succeed Ana M. Chadwick as Executive Vice President and Chief Financial Officer of the Company. Ms. Pease will assume the role on September 30, 2025, and Ms. Chadwick will remain with the Company as a Senior Advisor for a period of time to ens

View on Read The Filing